EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anticancer Activity of Bitter Melon-Derived Vesicles Extract against Breast Cancer

Ting Feng, Yilin Wan, Bin Dai, Yanlei Liu

Cells · 2023

DOI: 10.3390/cells12060824 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Ting Feng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Nano Biomedicine and Engineering, Shanghai Engineering Research Center for Intelligent Diagnosis and Treatment Instrument, Department of…. Hauptthemen laut MEDLINE: Breast Neoplasms, Momordica charantia. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Due to their low immunogenicity, high biocompatibility and ready availability in large quantities, plant-derived vesicles extracts have attracted considerable interest as a novel nanomaterial in tumor therapy. Bitter melon, a medicinal and edible plant, has been reported to exhibit excellent antitumor effects. It is well-documented that breast cancer gravely endangers women’s health, and more effective therapeutic agents must be urgently explored. Therefore, we investigated whether bitter melon-derived vesicles extract (BMVE) has antitumor activity against breast cancer. Ultracentrifugation was used to isolate BMVE with a typical “cup-shaped” structure and an average size of approximately 147 nm from bitter melon juice. The experimental outcomes indicate that 4T1 breast cancer cells could efficiently internalize BMVE, which shows apparent anti-proliferative and migration-inhibiting effects. In addition, BMVE also possesses apoptosis-inducing effects on breast cancer cells, which were achieved by stimulating the production of reactive oxygen species (ROS) and disrupting mitochondrial function. Furthermore, BMVE could dramatically inhibit tumor growth in vivo with negligible adverse effects. In conclusion, BMVE exhibits a pronounced antitumor effect on 4T1 breast cancer cells, which has great potential for use in tumor therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMomordica charantiaFemaleHumansPlant Extracts

Stichwörter der Autor:innen

antitumorbitter melonbreast cancermedicinal and edible plantsvesicles extract

Substanzen

Plant Extracts

Autor:innen und Institutionen

  • Institute of Nano Biomedicine and Engineering, Shanghai Engineering Research Center for Intelligent Diagnosis and Treatment Instrument, Department of Instrument Science and Engineering, School of Electronic Information…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Feng, T., Wan, Y., Dai, B., & Liu, Y. (2023). Anticancer Activity of Bitter Melon-Derived Vesicles Extract against Breast Cancer. Cells. https://doi.org/10.3390/cells12060824

Vancouver

Feng T, Wan Y, Dai B, Liu Y. Anticancer Activity of Bitter Melon-Derived Vesicles Extract against Breast Cancer. Cells. 2023. doi:10.3390/cells12060824

BibTeX
@article{Feng2023,
  author = {Feng, Ting and Wan, Yilin and Dai, Bin and Liu, Yanlei},
  title = {Anticancer Activity of Bitter Melon-Derived Vesicles Extract against Breast Cancer},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12060824}
}
Kostenlos starten →